As of 2025-07-01, the Intrinsic Value of Natus Medical Inc (NTUS) is 7.51 USD. This NTUS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 32.96 USD, the upside of Natus Medical Inc is -77.20%.
The range of the Intrinsic Value is 6.33 - 9.97 USD
Based on its market price of 32.96 USD and our intrinsic valuation, Natus Medical Inc (NTUS) is overvalued by 77.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 6.33 - 9.97 | 7.51 | -77.2% |
| DCF (Growth 10y) | 6.83 - 10.36 | 7.99 | -75.7% |
| DCF (EBITDA 5y) | 9.50 - 13.59 | 11.70 | -64.5% |
| DCF (EBITDA 10y) | 8.56 - 12.93 | 10.76 | -67.4% |
| Fair Value | 3.33 - 3.33 | 3.33 | -89.89% |
| P/E | 10.83 - 13.31 | 12.91 | -60.8% |
| EV/EBITDA | 19.04 - 31.54 | 25.44 | -22.8% |
| EPV | 15.99 - 20.65 | 18.32 | -44.4% |
| DDM - Stable | 2.99 - 7.97 | 5.48 | -83.4% |
| DDM - Multi | 3.54 - 7.46 | 4.81 | -85.4% |
| Market Cap (mil) | 1,139.85 |
| Beta | 0.23 |
| Outstanding shares (mil) | 34.58 |
| Enterprise Value (mil) | 1,139.85 |
| Market risk premium | 4.24% |
| Cost of Equity | 8.36% |
| Cost of Debt | 4.25% |
| WACC | 8.36% |